[ What drug strategies are advisable for patients with advanced-stage Parkinson's].
Brefel-Courbon
C
C
Service de Pharmacologie Medicale et Clinique, Faculte de Medecine, Toulouse.
D000367:Age Factors; D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D018450:Disease Progression; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology
D000978:Antiparkinson Agents; D007980:Levodopa